Three Stocks to Surpass Palantir by 2028

Palantir Technologies, that restless colossus of modern finance, still casts a long shadow over the market, though its gait has softened of late. Investors, like moths to a flickering flame, ponder whether to buy its dip. Yet the historian in me inclines toward a different vantage: three enterprises, each a study in patience and purpose, may yet eclipse it by 2028.

1. Alibaba: The Silk Road Reimagined

To chase Palantir’s AI-driven fervor is to court a tempest. Alibaba, however, offers the measured cadence of a river carving its path through time. With a market cap of $282 billion against Palantir’s $370 billion, the gap seems but a fleeting shadow. Alibaba’s P/E ratio-13.8-dances like a waltz compared to Palantir’s frenzied quadrille at 244. Even its PEG ratio, a stately 1.25, whispers of prudence where Palantir shouts.

Loading widget...

China’s ambition to dominate AI is no secret; it is etched into the very bones of its infrastructure. Alibaba, as both cloud architect and AI pioneer, stands not merely as a participant but as a weaver of destiny. Its growth, like a dormant vine, will soon unfurl with vigor, nourished by the soil of national purpose.

2. ASML: The Dutch Master of Microscopic Realms

ASML, that quiet titan of the Netherlands, operates in a world where light bends to its will. Unlike Alibaba’s bustling markets, its domain is one of precision-extreme ultraviolet lithography, a craft so rare it borders on alchemy. Its P/E ratio, 26.7, and PEG of 1.51, are not mere numbers but the measured breath of a craftsman at work.

Loading widget...

While nations chase AI’s mirage, ASML holds the key to its kingdom: the chips that give it life. By 2030, its revenue may double, a crescendo in a symphony of silicon. Palantir, for all its haste, cannot match this quiet mastery. The historian notes: empires rise not through clamor, but through the silent accumulation of irreplaceable skill.

3. UnitedHealth Group: The Phoenix of Healthcare

Once, UnitedHealth Group soared above the clouds with a $500 billion market cap. Now, storms gather-rising medical costs, the shadow of DOJ investigations. Yet the phoenix, though scorched, does not perish. Its 2026 premium hikes will offset costs, and history whispers that it has weathered tempests before.

Loading widget...

Shares trade at their lowest multiples in a decade, a forgotten lullaby for those who dare to listen. Warren Buffett and David Tepper, those sages of the market, have already taken notice. As for Palantir? Let us say it lacks the gravitas to attract such discerning eyes. 🕊️

Read More

2025-08-25 12:25